Platelet-activating factor-induced NF-kappaB activation enhances VEGF expression through a decrease in p53 activity

FEBS Lett. 2006 May 29;580(13):3006-12. doi: 10.1016/j.febslet.2006.04.042. Epub 2006 Apr 25.

Abstract

We investigated the role of p53 in nuclear factor (NF)-kappaB dependent, platelet-activating factor (PAF)-induced vascular endothelial growth factor (VEGF) expression. Transfected NF-kappaB subunits in ECV304 cells increased the tumor necrosis factor-alpha promoter activity, which was completely inhibited by p53. Transfected p53 increased p53RE promoter activity, which was completely inhibited by NF-kappaB subunits, indicating that cross-regulation occurs between NF-kappaB and p53. PAF-induced increase in VEGF expression was correlated with decreased p53 activity. These data suggest that NF-kappaB-dependency of the PAF-induced increase in VEGF expression is due to decreased p53 activity, which is reciprocally regulated by increased NF-kappaB activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Down-Regulation
  • Humans
  • Platelet Activating Factor / pharmacology*
  • Platelet Activating Factor / physiology*
  • Promoter Regions, Genetic / drug effects*
  • Transcription, Genetic
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism*
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Platelet Activating Factor
  • Tumor Necrosis Factor-alpha
  • Tumor Suppressor Protein p53
  • Vascular Endothelial Growth Factor A